Healthcare Value Capital, LLC 13F 持仓 · 最近申报 2021年Q3
Healthcare Value Capital 在 2021年Q3（报告期截至 2021-09-30）的 SEC 13F 申报中报告了 18 只证券，申报市值合计 5,065.40 万美元。前几大持仓：ALKS（12.18%）、PFE（10.62%）、GILD（8.27%）。本季前 25 大持仓中：新建仓 3 只、增持 7 只、减持 4 只、清仓 2 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | ALKS | ALKERMES PLC | $6.2M | 12.18% | 200,000 | 增持 |
| 2 | PFE | PFIZER INC | $5.4M | 10.62% | 125,000 | 增持 |
| 3 | GILD | GILEAD SCIENCES INC | $4.2M | 8.27% | 60,000 | 减持 |
| 4 | GSK | GLAXOSMITHKLINE PLC | $3.8M | 7.54% | 100,000 | 持平 |
| 5 | AMYT | AMRYT PHARMA PLC | $3.0M | 5.97% | 250,000 | 增持 |
| 6 | AZN | ASTRAZENECA PLC | $3.0M | 5.93% | 50,000 | 持平 |
| 7 | MRK | MERCK & CO INC | $3.0M | 5.93% | 40,000 | 持平 |
| 8 | BMY | BRISTOL-MYERS SQUIBB CO | $3.0M | 5.84% | 50,000 | 持平 |
| 9 | SPXU | PROSHARES TR | $2.6M | 5.19% | 150,000 | 增持 |
| 10 | IRWD | IRONWOOD PHARMACEUTICALS INC | $2.6M | 5.16% | 200,000 | 减持 |
| 11 | CLVS | CLOVIS ONCOLOGY INC | $2.2M | 4.40% | 500,000 | 持平 |
| 12 | TYME | TYME TECHNOLOGIES INC | $2.1M | 4.07% | 2.0M | 增持 |
| 13 | ATRS | ANTARES PHARMA INC | $1.8M | 3.59% | 500,000 | 持平 |
| 14 | SQQQ | PROSHARES TR | $1.7M | 3.41% | 200,000 | 增持 |
| 15 | UVXY | PROSHARES TR II | $1.2M | 2.42% | 50,000 | 新建仓 |
| 16 | AMRN | AMARIN CORP PLC | $1.0M | 2.01% | 200,000 | 持平 |
| 17 | VRTX | VERTEX PHARMACEUTICALS INC | $907,000 | 1.79% | 5,000 | 新建仓 |
| 18 | GNLN | GREENLANE HLDGS INC | $830,000 | 1.64% | 350,000 | 持平 |
| 19 | VYNE | VYNE THERAPEUTICS INC | $556,000 | 1.10% | 400,000 | 减持 |
| 20 | ADMS | ADAMAS PHARMACEUTICALS INC | $491,000 | 0.97% | 100,000 | 持平 |
| 21 | GMDAQ | GAMIDA CELL LTD | $392,000 | 0.77% | 100,000 | 增持 |
| 22 | DRRX | DURECT CORP | $320,000 | 0.63% | 250,000 | 新建仓 |
| 23 | VIXY | PROSHARES TR II | $285,000 | 0.56% | 12,500 | 减持 |
| 24 | COLL | COLLEGIUM PHARMACEUTICAL INC | $0 | 0.00% | 0 | 清仓 |
| 25 | MDXG | MIMEDX GROUP INC | $0 | 0.00% | 0 | 清仓 |
来源：SEC 13F 申报文件 · 截至 2021-09-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR